DENND1A and polycystic ovary syndrome: Functional studies have shown the involvement of DENND1A in the pathophysiology of PCOS phenotypes, with laboratory studies demonstrating that ovarian thecal cells in PCOS affected women secrete higher androgen amounts than those from non-affected women, potentially related to upregulation of enzymatic activity in steroid pathways [22].